Tải bản đầy đủ (.pdf) (3 trang)

Andersons pediatric cardiology 287

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (83.69 KB, 3 trang )

CriticalAppraisal
Moststudiesthatreportestimatesofprevalencearespecificallydesignedtodo
soandhaveitastheprimaryaimofthestudy.Beforeacceptingtheresultsof
thesestudies,itisimportantcriticallytoappraisethemethodsandreporting,to
determineifthefindingsarevalid,reliable,andrelevant.Criticalappraisalis
alsorequiredwhenonewishestocompareestimatesarisingfromdifferent
studies,suchascomparisonsoftrendsovertimeoracrossdifferentpopulations.
Considerationmustbegiventoalloftheaspectsbywhichthedenominatorand
numeratoraredefinedandderivedandtotheadequacyofreportingofthe
associatedmethodsandresults.InBox13.1,questionsforwhichtheanswers
shouldbeevidentwhencriticallyappraisingareportregardingprevalenceare
noted.


Box13.1

QuestionsforCriticallyAppraisingaReport
AboutPrevalence
▪Whatwasthestatedpurposeoraimofthestudy?
▪Howaccurateandvalidwastheestimatereported?
▪Howaccurateandvalidwasthedefinitionandcompletenessofthe
numerator?
▪Whatformsofcongenitalheartdiseasewereincludedor
excluded?
▪Whatnomenclatureandsystemofclassificationwasusedto
describeandgroupcases?
▪Whatwerethemethodsbywhichcaseswereascertained
andreported?
▪Whatwastheoveralldesignofthestudyanddata
collection?
▪Howwerecasesdetectedandreportedfromthepopulation


studied?
▪Whatfactors,particularlyrelatingtothesystemforhealth


care,mayhaveinfluencedtheascertainmentofcases?
Specifically,dideveryoneinthepopulationstudiedhave
equalaccesstohealthcareandthereferralcenter,andwas
screeningandverificationinfluencedbydifferencesin
qualityandavailabilityofexpertiseortechnology?
▪Howwerediagnosesconfirmedorverified?
▪Howlongwasthefollow-up,andwasitsufficientlylongto
capturecaseswithlaterclinicalmanifestation?
▪Ifauniversalscreeningwasapplied,wasitappliedequally
totheentirepopulationatanearlyenoughtimepoint,was
itsufficientlysensitiveandspecific,andwasanassessment
ofverificationperformed?
▪Howaccurateandvalidwasthedefinitionandcompletenessofthe
denominator?
▪Whatwasthedefinitionofthepopulationstudied?
▪Whatwerethesourcesofdatausedtoderivethe
denominator,andweretheyvalidandreliable?
▪Howaccuratelyandcompletelydoesthepopulationstudied
reflectthetargetpopulationorpopulationatlarge?
▪Arethecasescompletedderivedfromthepopulation
studiedasdefinedinthedenominator?Werethecasesand
populationcharacterizedaspartofthesamestudywiththe
samemethodology,asinacohortstudy?
▪Howreliableistheestimateofprevalenceestimate?Areconfidence
intervalsprovided?
▪Howdoestheestimatefromthestudycomparewiththosereportedfrom

otherstudieswithcomparablemethodology?
▪Istheestimateapplicabletoyourownclinicalpopulation?Isthepopulation
studiedsimilartoyourownclinicalpopulationintermsofsetting,time,
geography,anddemographiccharacteristics?Istheestimateofprevalence
relevanttoyourownclinicalorresearchquestion?


FactorsInfluencingEstimatesof
Prevalence
Ideally,factorsthatmighthaveatruecausalrelationshiptothedevelopmentof
congenitalcardiacdiseaseandhenceinfluencethetrueincidenceshouldbe
identified.Identificationofsuchfactorsmayallowforthepreventionof
congenitalcardiacdiseaseorprovidenewknowledgeastoetiologyand
development.Theidentificationoftheseassociationscomesmainlyfrom
observationalstudies.

EnvironmentalFactors
Themostwidelyheldbeliefisthatcongenitalcardiacdiseaseistheproductof
aninteractionbetweengeneticandenvironmentalfactors.However,evidence
hasyettoprogresssufficientlyfartoprovethisnotion,althoughadvancesinthe
understandingofgeneticunderpinningscontinuetoincrease.Forexample,
recentstudieshavesuggestedthepresenceofaninteractionbetweenmaternal
genesandmaternalexposurestoaromatichydrocarbonsandcongenitalheart
disease.7Numerousenvironmentalfactorshavebeenlinkedtosuch
development,independentofanyalreadyknowngeneticinfluenceor
predisposition.4
AscientificstatementfromtheAmericanHeartAssociationreviewedstudies
ofprevalenceandsummarizedstudiesofenvironmentalfactors.8InTable13.3,
positiveassociationsformaternalillnessesandmaternalexposuresare
highlighted.

Table13.3
FetalExposuresandIncreasedRiskofCongenitalHeartDefectsa
OddsRatio
MATERNALILLNESS
Phenylketonuria52–55
Pregestationaldiabetes56–59
Febrileillness56,60–62
Influenza62,63
Maternalrubella64

>6
3.1–18
1.8–2.9
2.1
b



×